Phase 2 Ovarian Cancer Trial, Recruiting

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who have been diagnosed with recurrent primary mucinous ovarian cancer, confirmed through laboratory testing of a tissue or cell sample
• People aged 18 or older
• People who are reasonably able to carry out daily activities (assessed using a standard health scale, confirm with trial site)
• People whose blood counts and organ function meet specific levels when tested within 30 days before registering — including white blood cell counts, platelet counts, and liver and kidney function readings
• People who have had their last chemotherapy or radiation treatment more than 2 weeks before joining (or more than 6 weeks if the treatment was bevacizumab)
• People who are willing and able to sign an informed consent form, either themselves or through a legally authorised representative

Who may not be able to join:

• People who are currently taking part in another experimental treatment trial, or who have received an unapproved experimental treatment within 30 days before the procedure
• People whose mucinous tumour has been confirmed by pathology to have originated from somewhere other than the gynaecological system
• People with known active cancer spread to the brain or central nervous system
• People with a known allergy or sensitivity to cisplatin or any of its ingredients
• People with an uncontrolled illness such as an active infection, unstable heart condition, unmanaged heart rhythm problems, or mental health or personal circumstances that may affect participation
• People who are currently pregnant or breastfeeding
• People with moderate to severe nerve damage in their hands or feet (confirm with trial site)
• People who have previously had an organ or tissue transplant from another person
• People who have previously had a specific type of chemotherapy delivered directly into the abdomen (HIPEC or intraperitoneal chemotherapy)
• People with known large areas of cancer spread outside the abdomen and pelvis
• People with moderate to severe hearing loss or ringing in the ears

Note: People with a history of another cancer may still be considered eligible, depending on whether that cancer or its treatment could affect the safety or results of this trial — the trial site would assess this individually.

Important: Always verify eligibility with the trial site directly before applying.